Edward Wright

3.0k total citations
70 papers, 1.6k citations indexed

About

Edward Wright is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Edward Wright has authored 70 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Infectious Diseases, 22 papers in Epidemiology and 17 papers in Virology. Recurrent topics in Edward Wright's work include Viral Infections and Outbreaks Research (17 papers), Viral Infections and Vectors (15 papers) and Rabies epidemiology and control (11 papers). Edward Wright is often cited by papers focused on Viral Infections and Outbreaks Research (17 papers), Viral Infections and Vectors (15 papers) and Rabies epidemiology and control (11 papers). Edward Wright collaborates with scholars based in United Kingdom, Netherlands and United States. Edward Wright's co-authors include Anthony R. Fooks, Nigel Temperton, Robin A. Weiss, Ashley C. Banyard, Lorraine M. McElhinney, Osbourne Quaye, Denise A. Marston, Leonard Both, Julian K‐C. and Craig J. van Dolleweerd and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Edward Wright

69 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward Wright United Kingdom 22 647 529 449 313 297 70 1.6k
Andrea Lisco United States 26 743 1.1× 668 1.3× 848 1.9× 230 0.7× 787 2.6× 76 2.1k
Eftyhia Vardas South Africa 23 493 0.8× 1.5k 2.8× 401 0.9× 145 0.5× 440 1.5× 52 2.4k
Marcelo A. Soares Brazil 25 958 1.5× 802 1.5× 925 2.1× 93 0.3× 285 1.0× 134 2.2k
Jolanta Kurz Canada 7 985 1.5× 1.0k 2.0× 271 0.6× 196 0.6× 170 0.6× 11 2.5k
Elizabeth A. Dragon United States 16 586 0.9× 689 1.3× 955 2.1× 159 0.5× 685 2.3× 22 2.0k
Peter Hayes United Kingdom 24 531 0.8× 541 1.0× 588 1.3× 73 0.2× 474 1.6× 59 1.7k
Karen S. Slobod United States 26 469 0.7× 1.2k 2.3× 418 0.9× 482 1.5× 633 2.1× 70 2.3k
Lilin Lai United States 20 561 0.9× 669 1.3× 641 1.4× 249 0.8× 811 2.7× 43 1.8k
Ronald J. Messer United States 29 315 0.5× 517 1.0× 454 1.0× 157 0.5× 1.5k 5.0× 51 2.2k
Ian J. Amanna United States 22 960 1.5× 896 1.7× 510 1.1× 408 1.3× 1.3k 4.3× 42 3.0k

Countries citing papers authored by Edward Wright

Since Specialization
Citations

This map shows the geographic impact of Edward Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Wright more than expected).

Fields of papers citing papers by Edward Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Wright. The network helps show where Edward Wright may publish in the future.

Co-authorship network of co-authors of Edward Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Wright. A scholar is included among the top collaborators of Edward Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Wright. Edward Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quaye, Osbourne, Edward Wright, Emmanuel Broni, et al.. (2023). Structure-Based Identification of Natural-Product-Derived Compounds with Potential to Inhibit HIV-1 Entry. Molecules. 28(2). 474–474. 3 indexed citations
2.
Cantoni, Diego, Craig Wilkie, Emma Bentley, et al.. (2023). Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature. Frontiers in Immunology. 14. 1184362–1184362. 19 indexed citations
3.
Cantoni, Diego, Martin Mayora Neto, Claude Sabeta, et al.. (2023). Serological evidence of virus infection in Eidolon helvum fruit bats: implications for bushmeat consumption in Nigeria. Frontiers in Public Health. 11. 1283113–1283113. 3 indexed citations
4.
Bagley, Mark C., et al.. (2022). Synthesis and Evaluation of a Silver Nanoparticle/Polyurethane Composite That Exhibits Antiviral Activity against SARS-CoV-2. Polymers. 14(19). 4172–4172. 14 indexed citations
5.
Neto, Martin Mayora, Edward Wright, Nigel Temperton, et al.. (2022). Application and comparison of lyophilisation protocols to enhance stable long-term storage of filovirus pseudotypes for use in antibody neutralisation tests. Journal of Applied Microbiology. 134(2). 3 indexed citations
6.
Bentley, Emma, Pramila Rijal, Alain Townsend, et al.. (2021). Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay. Tropical Medicine and Infectious Disease. 6(3). 155–155. 5 indexed citations
7.
James, Joe, Shelley Rhodes, Craig S. Ross, et al.. (2021). Comparison of Serological Assays for the Detection of SARS-CoV-2 Antibodies. Viruses. 13(4). 713–713. 20 indexed citations
8.
Searyoh, Kafui, et al.. (2020). Genotypic Characterization of Epstein Barr Virus in Blood of Patients with Suspected Nasopharyngeal Carcinoma in Ghana. Viruses. 12(7). 766–766. 12 indexed citations
9.
Steeds, Kimberley, Yper Hall, Gillian S. Slack, et al.. (2020). Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies. Scientific Reports. 10(1). 14289–14289. 12 indexed citations
10.
Benedictis, Paola De, Andrea Minola, Angela Salomoni, et al.. (2016). Development of broad‐spectrum human monoclonal antibodies for rabies post‐exposure prophylaxis. EMBO Molecular Medicine. 8(4). 407–421. 73 indexed citations
11.
Welfare, William & Edward Wright. (2016). Planning for the unexpected: Ebola virus, Zika virus, what's next?. British Journal of Hospital Medicine. 77(12). 704–707. 5 indexed citations
12.
Both, Leonard, Ashley C. Banyard, Craig J. van Dolleweerd, et al.. (2013). Monoclonal antibodies for prophylactic and therapeutic use against viral infections. Vaccine. 31(12). 1553–1559. 72 indexed citations
13.
Liu, Dawei, Tiejun Gu, Chunlai Jiang, et al.. (2013). Single Domain Antibody Multimers Confer Protection against Rabies Infection. PLoS ONE. 8(8). e71383–e71383. 18 indexed citations
14.
Wright, Edward, Paul R. Grant, Rosalind Parkes‐Ratanshi, et al.. (2011). Coreceptor and Cytokine Concentrations May Not Explain Differences in Disease Progression Observed in HIV-1 Clade A and D Infected Ugandans. PLoS ONE. 6(5). e19902–e19902. 2 indexed citations
15.
Wright, Edward, Daniel L. Horton, Tiziana Lembo, et al.. (2009). A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa. Vaccine. 27(51). 7178–7186. 39 indexed citations
16.
Wright, Edward, Nigel Temperton, Robin A. Weiss, et al.. (2007). A novel serological assay for detection of rabies virus neutralising antibodies. PLoS ONE. 9(3). e92558–e92558. 1 indexed citations
17.
Rifkin, Susan B., et al.. (1995). The pursuit of equity: a health sector case study from Vietnam. Health Policy. 33(3). 191–204. 14 indexed citations
19.
Wright, Edward. (1992). Immunological Techniques in and for Developing Countries. Scandinavian Journal of Immunology. 36(s1). 145–148. 3 indexed citations
20.
Long, H. T., et al.. (1988). Responses to Mycobacterium leprae by lymphocytes from new and old leprosy patients: Role of exogenous lymphokines. Annales de l Institut Pasteur Immunologie. 139(2). 121–133. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026